... that could boost the immune response while working with the immune response generated by the SBRT. Cancer immunotherapy works to boost the body's own immune system to attack tumor cells. They found ...
LA JOLLA, Calif., Oct. 22 (UPI) -- U.S. medical scientists say they are working to develop new human immunotherapy in an effort to increase both innate and adaptive cancer immunity.
... Clinical Investigation. Head of the Burnet Institute's Cancer Immunotherapy Laboratory, Associate Professor Pei ... men die each year from prostate cancer, equal to the number of women who die from breast ...
... ."
Sipuleucel-T is an investigational therapy for men with androgen-independent prostate cancer. It is an active cellular immunotherapy designed to use live human cells to boost a patient's immune ...
SEATTLE, May 5 (UPI) -- U.S. scientists have determined sipuleucel-T, a prostate cancer immunotherapy drug, significantly prolongs survival in men with advanced prostate cancer.
... immune dysfunctions seen in many cancer patients and why cancer immunotherapies are often ineffective. "Over half ... mount an immune response against their own cancer," said hematologist Peter P. Lee, MD ...
... negative group is triple-negative breast cancer (TNBC), which lacks the estrogen, progesterone and HER2 ... trials of a MAGEA3-based cancer vaccine, or "antigen-specific cancer immunotherapy" (ASCI) in non ...
Post-transplant steroid therapy: Unneeded? ... Physicists discover new state of matter ... Study seeks new cancer immunotherapy ... Study: Ripe bananas look blue in UV ...
... Sadelain and colleagues, at Memorial Sloan-Kettering Cancer Center, New York, have developed a new ... -regulated therapeutic gene expression in stem cell–based therapies, including cancer immunotherapy. ...
... explain the beneficial effects of the TLR9 stimulatory drugs being developed to boost the efficiacy of cancer immunotherapies and vaccines.
TITLE: Ligation of TLR9 induced on human IL-10–secreting ...
... cells' growth and production could one day lead to better vaccines and possibly more effective cancer immunotherapy, said researchers at Baylor College of Medicine and Texas Children's Hospital in a ...
... trial.
Melanoma, the most dangerous kind of skin cancer, takes about 60,000 lives a year ... possible with standard therapies.
While the field of cancer immunotherapy – employing the body's own immune ...
